TGA green-lights 'life-changing' drug to treat SMA

By Esther Han and Kate Aubusson
Updated November 22 2017 - 9:53am, first published November 4 2017 - 2:55pm
Baby Aviana, who has SMA, has celebrated her first birthday, a rare feat.
Baby Aviana, who has SMA, has celebrated her first birthday, a rare feat.

A drug that can extend the life of children and adults with spinal muscular atrophy (SMA) has been approved by the Therapeutic Goods Administration and is now commercially available.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Wollongong news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.